Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H.
Genitrix, LLC, Cambridge, MA, United States
Search 10 grants from Andrew Segal
Search grants from Genitrix, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Advanced Training in Nursing Outcomes Research
Autophagy in epidermal melanocyte: a protective or a destructive role?
A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc
Increasing Diversity in Experiential Research Education at Michigan State Univ
Control of B Cell Terminal Differentiation - Role of CD40
Recently added grants:
CommunityRx for Hunger - Resubmission 01
Psychiatric and substance use disorders in Puerto Rico before and after Hurricane Maria
Sex Differences in Aversion-Resistant Ethanol Intake
A Role for IL-1Beta in Ethanol Withdrawal-Induced Increase of PTSD-Like Phenotype
Analyzing the Impacts of Two Influential Early Childhood Programs on Participants through Midlife
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43CA074665-01A1S1
Application #
6021665
Study Section
Special Emphasis Panel (ZRG2 (02))
Program Officer
Reynolds, Craig W
Project Start
1997-09-30
Project End
1999-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Genitrix, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1999
R43 CA
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H. / Genitrix, LLC
NIH 1997
R43 CA
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H. / Genitrix, LLC
Comments
Be the first to comment on Andrew Segal's grant